Calcium supplementation and risk of dementia in women with cerebrovascular disease
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To determine whether calcium supplementation is associated with the development of dementia in women after a 5-year follow-up.
Methods: This was a longitudinal population-based study. The sample was derived from the Prospective Population Study of Women and H70 Birth Cohort Study in Gothenburg, Sweden, and included 700 dementia-free women aged 70–92 years. At baseline in 2000–2001, and at follow-up in 2005–2006, the women underwent comprehensive neuropsychiatric and somatic examinations. A CT scan was performed in 447 participants at baseline. Information on the use and dosage of calcium supplements was collected. Dementia was diagnosed according to DSM-III-R criteria.
Results: Women treated with calcium supplements (n = 98) were at a higher risk of developing dementia (odds ratio [OR] 2.10, 95% confidence interval [CI] 1.01–4.37, p = 0.046) and the subtype stroke-related dementia (vascular dementia and mixed dementia) (OR 4.40, 95% CI 1.54–12.61, p = 0.006) than women not given supplementation (n = 602). In stratified analyses, calcium supplementation was associated with the development of dementia in groups with a history of stroke (OR 6.77, 95% CI 1.36–33.75, p = 0.020) or presence of white matter lesions (OR 2.99, 95% CI 1.28–6.96, p = 0.011), but not in groups without these conditions.
Conclusions: Calcium supplementation may increase the risk of developing dementia in elderly women with cerebrovascular disease. Because our sample was relatively small and the study was observational, these findings need to be confirmed.
GLOSSARY
- AD=
- Alzheimer disease;
- CI=
- confidence interval;
- DSM-III-R=
- Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised;
- ICD=
- International Classification of Diseases;
- MMSE=
- Mini-Mental State Examination;
- OR=
- odds ratio;
- VaD=
- vascular dementia;
- WHI CaD=
- Women's Health Initiative Calcium/Vitamin D supplementation study;
- WML=
- white matter lesion
Footnotes
↵* These authors contributed equally to this work.
↵‡ These authors share last authorship.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received January 16, 2016.
- Accepted in final form July 5, 2016.
- © 2016 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Author response to Dr. Beale
- Silke Kern, MD, PhD, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Asilke.kern@neuro.gu.se
- J. Kern; K. Blennow; H. Zetterberg; M. Waern; X. Guo; A. B?rjesson-Hanson; I. Skoog; S. ?stling
Submitted October 28, 2016 - Methodology leads to unreliable results
- David J. Beale, Clinical Pharmacist, CVS Healthdbeale01@gmail.com
Submitted October 21, 2016 - Author Response to Dr. Rosenberg
- Silke Kern, MD, PhD, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Asilke.kern@neuro.gu.se
- J. Kern, K. Blennow, H. Zetterberg, M. Waern, X. Guo, A. Borjesson-Hanson, I. Skoog, S. Ostling
Submitted September 28, 2016 - Calcium-associated dementia risk
- Gilad Rosenberg, Medical Director, Clal Biotechnology Industriesg.rosenberg.md@gmail.com
Submitted September 23, 2016
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Dietary intake of vitamin D and cognition in older womenA large population-based studyC. Annweiler, A.M. Schott, Y. Rolland et al.Neurology, November 15, 2010 -
Articles
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home servicesJ. S. Buell, B. Dawson-Hughes, T. M. Scott et al.Neurology, November 25, 2009 -
Article
Vitamin D and the risk of dementia and Alzheimer diseaseThomas J. Littlejohns, William E. Henley, Iain A. Lang et al.Neurology, August 06, 2014 -
WriteClick® Editor's Choice
Letter re: Calcium supplementation and risk of dementia in women with cerebrovascular diseaseGilad Rosenberg et al.Neurology, February 20, 2017